Journal article icon

Journal article

Influence of Hypoxia on the Epithelial-Pathogen Interactions in the Lung: Implications for Respiratory Disease

Abstract:
Under normal physiological conditions, the lung remains an oxygen rich environment. However, prominent regions of hypoxia are a common feature of infected and inflamed tissues and many chronic inflammatory respiratory diseases are associated with mucosal and systemic hypoxia. The airway epithelium represents a key interface with the external environment and is the first line of defense against potentially harmful agents including respiratory pathogens. The protective arsenal of the airway epithelium is provided in the form of physical barriers, and the production of an array of antimicrobial host defense molecules, proinflammatory cytokines and chemokines, in response to activation by receptors. Dysregulation of the airway epithelial innate immune response is associated with a compromised immunity and chronic inflammation of the lung. An increasing body of evidence indicates a distinct role for hypoxia in the dysfunction of the airway epithelium and in the responses of both innate immunity and of respiratory pathogens. Here we review the current evidence around the role of tissue hypoxia in modulating the host-pathogen interaction at the airway epithelium. Furthermore, we highlight the work needed to delineate the role of tissue hypoxia in the pathophysiology of chronic inflammatory lung diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease in addition to novel respiratory diseases such as COVID-19. Elucidating the molecular mechanisms underlying the epithelial-pathogen interactions in the setting of hypoxia will enable better understanding of persistent infections and complex disease processes in chronic inflammatory lung diseases and may aid the identification of novel therapeutic targets and strategies.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.3389/fimmu.2021.653969

Authors

More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-7435-1813
More by this author
Role:
Author
ORCID:
0000-0003-3844-6457
More by this author
Role:
Author
ORCID:
0000-0001-7273-0844
More by this author
Role:
Author
ORCID:
0000-0002-6735-2567
More by this author
Role:
Author
ORCID:
0000-0003-1771-3851


Publisher:
Frontiers Media
Journal:
Frontiers in Immunology More from this journal
Volume:
12
Pages:
653969-653969
Publication date:
2021-03-24
DOI:
EISSN:
1664-3224
ISSN:
1664-3224


Language:
English
Keywords:
Pubs id:
2363946
UUID:
uuid_0f6cacad-dd0a-4f4c-bd3e-0dee3c31be0b
Local pid:
pubs:2363946
Source identifiers:
W3137034646
Deposit date:
2026-01-27
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP